Ticker
NPCECompany Name
NEUROPACE INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -16.09M | -18.17% | $ 88.57M |
3/31/2025 | $ -17.9M | -21.24% | $ 84.31M |
12/31/2024 | $ -17.95M | -22.46% | $ 79.91M |
9/30/2024 | $ -16.49M | -21.57% | $ 76.45M |
6/30/2024 | $ -17.07M | -23.77% | $ 71.82M |
3/31/2024 | $ -17.53M | -25.38% | $ 69.07M |
12/31/2023 | $ -19.7M | -30.11% | $ 65.42M |
9/30/2023 | $ -24.2M | -40.21% | $ 60.2M |
6/30/2023 | $ -28.88M | -52.57% | $ 54.93M |
3/31/2023 | $ -35.17M | -72.35% | $ 48.62M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for NEUROPACE INC is calculated as follows: CF - Operations [ $ -21.61M ] / Revenues [ $ 41.14M ]
(=) OCF % [ -52.53% ]
Minimum
Sep 30, 2022
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |